Dlk Investment Management, LLC Spero Therapeutics, Inc. Transaction History
Dlk Investment Management, LLC
- $239 Billion
- Q1 2025
A detailed history of Dlk Investment Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 29,825 shares of SPRO stock, worth $85,896. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,825
Previous 28,955
3.0%
Holding current value
$85,896
Previous $29.8 Million
28.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SPRO
# of Institutions
43Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX3.8MShares$10.9 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$5.08 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.9 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.8 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.56 Million0.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $101M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...